Testing effectiveness (Phase 2)Study completedNCT01634087
What this trial is testing
Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis
Who this might be right for
Plaque Psoriasis
Incyte Corporation 50
Showing 6 of 6 results